Loading...
XTSE
ACB
Market cap933mUSD
Jul 09, Last price  
3.83CAD
1D
0.79%
1Q
-19.54%
Jan 2017
-98.61%
IPO
-98.21%
Name

Aurora Cannabis Inc

Chart & Performance

D1W1MN
XTSE:ACB chart
P/E
P/S
4.12
EPS
Div Yield, %
Shrs. gr., 5y
27.38%
Rev. gr., 5y
5.50%
Revenues
321m
-6.61%
052,01040,8340000001,439,00018,067,00055,196,000245,536,000268,703,000245,252,000221,339,000223,804,000270,281,000343,293,000320,593,000
Net income
-136m
L
1,267-177,286-145,659-43,906-322,497-315,760-393,489-399,705-9,518,369-5,723,000-12,968,00071,936,000-293,509,000-3,282,694,000-693,625,000-1,717,624,000-816,627,000-69,326,0001,591,000-135,964,000
CFO
-14m
L
15,114-87,256-39,037-3,084-275,478-277,979-447,844-965,106-3,324,178-6,772,000-13,378,000-81,667,000-192,245,000-342,142,000-210,577,000-110,267,000-115,821,000-68,508,00016,005,000-13,511,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Aurora Cannabis Inc., based in Edmonton, Canada, is a global enterprise focused on the cultivation, distribution, and sale of cannabis and cannabis-derived goods. Within Canada, the company provides both medical and recreational cannabis products. Its international operations include supplying wholesale medical cannabis to various regions, such as the European Union, Australia, the Caribbean, South America, and Israel. Additionally, Aurora distributes and sells hemp-derived cannabidiol (CBD) products within the United States market. The company's product offerings are extensive, featuring dried cannabis, cannabis oils, capsules, edible cannabis, and concentrated extracts. These products can be consumed through various methods, including smoking, vaporizing, or ingestion in oil, capsule, edible, or extract forms. Aurora also offers dried milled strains and specific cannabis oil formulations, alongside patient counseling and outreach services. Its adult-use brand collection features names like Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, while its CBD offerings include Reliva and KG7. For medical cannabis patients, the company provides brands such as MedReleaf, CanniMed, Aurora, and WMMC.
IPO date
Sep 26, 2007
Employees
1,338
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT